Antimicrobial resistance (AMR) is a looming global health crisis, recently designated one of the top 10 public health threats facing humanity by the World Health Organisation (WHO).
AMR has the ability to render some of the most critical antimicrobial drugs ineffective. It can spread among microorganisms in health and agricultural settings, before making its way out into the environment and causing significant harm to human and animal hosts.
Losing effective antimicrobial treatments against infections would be catastrophic for health. Without preventative action, it is estimated that by 2050 AMR would lead to 10 million people dying every year and cost the global economy US$100 trillion.
Through research and consultation with multidisciplinary experts, this report has identified the key challenges and opportunities for Australia to improve prevention, detection, diagnosis, and response to drug resistant infections and reduce the impacts of AMR.
Overall, two high-level recommendations emerged from the project that will propel Australia forward to achieve its technology-powered, human-driven potential, and to prevent the rise and spread of AMR.
Recommendation 1: Establish centralised coordination and leadership for AMR management to align and coordinate domestic and international activities across human health, animal health and environmental health sectors.
Recommendation 2: Streamline and optimise the commercialisation process to support Australian AMR solutions entering the market.
28
February
Curbing antimicrobial resistance
Through research and consultation with multidisciplinary experts, this report has identified the key challenges and opportunities for Australia to improve prevention, detection, diagnosis, and response to drug resistant infections and reduce the impacts of AMR.
